Roth Capital Lifts Earnings Estimates for Moleculin Biotech
Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at Roth Capital lifted their Q1 2025 earnings per share (EPS) estimates for shares of Moleculin Biotech in a report issued on Monday, March 24th. Roth Capital analyst J. Aschoff now anticipates that the company will earn ($0.71) per share for the quarter, up from their […]
Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at Roth Capital lifted their Q1 2025 earnings per share (EPS) estimates for shares of Moleculin Biotech in a report issued on Monday, March 24th. Roth Capital analyst J. Aschoff now anticipates that the company will earn ($0.71) per share for the quarter, up from their […]
